Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. 2018

Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.

Based on previous work that established fused heterocycles as viable alternatives for the picolinamide core of our lead series of mGlu5 negative allosteric modulators (NAMs), we designed a novel series of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide mGlu5 NAMs. These new quinoline derivatives also contained carbon linkers as replacements for the diaryl ether oxygen atom common to our previously published chemotypes. Compounds were evaluated in a cell-based functional mGlu5 assay, and an exemplar analog 27 was >60-fold selective versus the other seven mGlu receptors. Selected compounds were also studied in metabolic stability assays in rat and human S9 hepatic fractions and exhibited a mixture of P450- and non-P450-mediated metabolism.

UI MeSH Term Description Entries
D008297 Male Males
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011804 Quinolines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
June 2013, ACS medicinal chemistry letters,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
January 2005, Current topics in medicinal chemistry,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
October 2022, ACS chemical biology,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
January 2020, Advances in pharmacology (San Diego, Calif.),
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
January 2004, Bioorganic & medicinal chemistry,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
June 2015, Bioorganic & medicinal chemistry letters,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
August 2011, ACS chemical neuroscience,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
July 2016, The international journal of neuropsychopharmacology,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
March 2011, Bioorganic & medicinal chemistry letters,
Andrew S Felts, and Alice L Rodriguez, and Ryan D Morrison, and Anna L Blobaum, and Frank W Byers, and J Scott Daniels, and Colleen M Niswender, and P Jeffrey Conn, and Craig W Lindsley, and Kyle A Emmitte
September 2003, Molecular pharmacology,
Copied contents to your clipboard!